Cite
Hardan AY, Jo B, Frazier TW, et al. A randomized double-blind controlled trial of everolimus in individuals with . Contemp Clin Trials Commun. 2021;21:100733doi: 10.1016/j.conctc.2021.100733.
Hardan, A. Y., Jo, B., Frazier, T. W., Klaas, P., Busch, R. M., Dies, K. A., Filip-Dhima, R., Snow, A. V., Eng, C., Hanna, R., Zhang, B., & Sahin, M. (2021). A randomized double-blind controlled trial of everolimus in individuals with . Contemporary clinical trials communications, 21100733. https://doi.org/10.1016/j.conctc.2021.100733
Hardan, Antonio Y, et al. "A randomized double-blind controlled trial of everolimus in individuals with ." Contemporary clinical trials communications vol. 21 (2021): 100733. doi: https://doi.org/10.1016/j.conctc.2021.100733
Hardan AY, Jo B, Frazier TW, Klaas P, Busch RM, Dies KA, Filip-Dhima R, Snow AV, Eng C, Hanna R, Zhang B, Sahin M. A randomized double-blind controlled trial of everolimus in individuals with . Contemp Clin Trials Commun. 2021 Feb 06;21:100733. doi: 10.1016/j.conctc.2021.100733. eCollection 2021 Mar. PMID: 33644493; PMCID: PMC7887633.
Copy
Download .nbib